About Beacon Bio
Beacon Bio is a Healthcare company based in United States founded in 2021 by Jennifer Lewis, Elliott Kozin, and Aaron Remenschneider. A regenerative tissue graft for eardrum repair is developed. Its focus areas include Life Sciences, ENT Disorders, Medical Devices and Therapeutic Devices. Its competitors include Advanced Bionics, Sofregen and Cerapedics; 3 of its 3 listed competitors have raised funding.
Company details
Beacon Bio was founded in 2021 in the United States within the biotechnology sector. Focus is placed on regenerative medicine, where a biodegradable device called PhonoGraft is created to address chronic eardrum perforations. The graft features a structure that mimics the natural eardrum and uses materials designed to integrate and remodel into functional tissue over time. Operations involve research and development for ear repair solutions.
- Headquarters United States
- Founders Jennifer Lewis, Elliott Kozin, Aaron Remenschneider
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website beacon-bio.com
People of Beacon Bio
3 people are tracked at Beacon Bio (3 in leadership).
| Name | Role | Group |
|---|---|---|
Jennifer Lewis | Co-Founder | Leadership |
Elliott Kozin | Co-Founder | Leadership |
Aaron Remenschneider | Co-Founder | Leadership |
Complete people profiles for Beacon Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Beacon Bio
Beacon Bio has 3 listed competitors in our database, 3 of them funded. They include Advanced Bionics, Sofregen and Cerapedics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| advancedbionics.com | 1993 | Valencia, United States | $78.06M | 687 | Provider of advanced cochlear implants and hearing technology for powerful connections | |
| sofregen.com | 2014 | Medford, United States | $17.8M | 8 | Silk-derived biomaterials are developed for soft tissue repair in surgery. | |
| cerapedics.com | 2006 | Westminster, United States | $88.46M | 3 | Osteobiologic products are developed using synthetic peptide technology. |
Detailed competitors of Beacon Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Organ-on-Chip & Regenerative Solutions
3 companies that operate in the same segment as Beacon Bio (Organ-on-Chip & Regenerative Solutions) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Human tissue-based products are developed for vascular disease applications. | 2004 | Morrisville, United States | USD 424.76 M | USD 2.04 M | 220 | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Synthetic adhesives for bone and dental repair are developed. | 2014 | Lowell, Massachusetts, United States | USD 24.42 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Beacon Bio
Beacon Bio was founded in 2021.
Beacon Bio is headquartered in United States.
Beacon Bio was founded in 2021 in the United States within the biotechnology sector. Focus is placed on regenerative medicine, where a biodegradable device called PhonoGraft is created to address chronic eardrum perforations. The graft features a structure that mimics the natural eardrum and uses materials designed to integrate and remodel into functional tissue over time. Operations involve research and development for ear repair solutions.
Beacon Bio's top competitors include Advanced Bionics, Cerapedics and Sofregen.